Amoora rohituka : A multicentric double blind homoeopathic pathogenetic trial

Authors

Rajpal Rajpal, Central Council for Research in Homoeopathy, New Delhi
Singh Vinay, Central Council for Research in Homoeopathy, New Delhi
Majumdar A, Drug Proving Research Unit (H), Kolkata, West Bengal
Chandra P, Drug Proving Research Unit (H), Kolkata, West Bengal
Rakshit Goutam, Drug Proving Research Unit (H), Bhubaneswar, Orissa
Sivadas P, Central Research Institute (H), Kottayam, Kerala

Keywords

homoeopathy; pathogenetic effect; homoeopathic pathogenetic trial; drug proving; amoora rohituka

Article Type

Original Article

Abstract

Objective: To elicit the pathogenetic response of the drug Amoora rohituka in homoeopathic potencies on healthy human beings. Methodology: Drug Amoora rohituka was proved by the Central Council for Research in Homoeopathy through double-blind placebo-controlled method. The study was conducted at three centers. The drug was proved in two potencies (6C and 30C) on 53 apparently healthy volunteers who were selected after conducting pre-trial medical examination by the medical specialists and routine laboratory investigations. In the first phase volunteers were given 56 doses (04 doses per day for 14 days) of placebo. In the next two phases 56 doses (04 doses per day for 14 days) of each potency or placebo were consumed. The symptoms generated during the trial period were noted by the volunteers and elaborated by the Proving Masters. The data obtained from all the three centers was compiled at proving-cum-data processing cell at CCRH headquarters after de- -coding.

Digital Object Identifier

10.53945/2320-7094.1708

Publisher

Wolters Kluwer India Pvt. Ltd.

How to cite this article

Rajpal R, Vinay S, A M, P C, Goutam R, P S. Amoora rohituka : A multicentric double blind homoeopathic pathogenetic trial. Indian J Res Homoeopathy 2011;5:6-14. doi: 10.53945/2320-7094.1708